Question 1

Who are the top researchers at PCI Biotech (Norway)?

Accepted Answer

Ranked on the quality score, Anders Høgset and Monika Håkerud lead among researchers whose main affiliation is PCI Biotech (Norway).

Question 2

What are the most cited papers from PCI Biotech (Norway)?

Accepted Answer

The most cited paper from PCI Biotech (Norway) is "Characterisation of Dynabeads® by magnetization measurements and Mössbauer spectroscopy" (Geir Fonnum, Christer Johansson, Astrid Molteberg et al., 2005), with 309 citations. Next come "Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules" (281) and "Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications" (275).

Question 3

Which research topics does PCI Biotech (Norway) publish most on?

Accepted Answer

By volume in 2022-now: Nanoplatforms for cancer theranostics, Ferroptosis and cancer prognosis, Photodynamic Therapy Research Studies and Bone Tissue Engineering Materials.

Question 4

Which keywords describe research at PCI Biotech (Norway)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Gene Therapy, Photodynamic Therapy, Reactive Oxygen Species, Cancer Treatment, Antimicrobial, Immunotherapy and Photosensitizers.

Question 5

Which fields of science does PCI Biotech (Norway) work in?

Accepted Answer

In all years, 44% of research at PCI Biotech (Norway) is in Life Sciences, 35% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (21%), Engineering (13%). It does 2.4× the world's share of Life Sciences.

Question 6

Is PCI Biotech (Norway)'s research output growing?

Accepted Answer

Output in 2022-2025 was 43% lower than in 2018-2021.